REGENXBIO INC (RGNX) Stock Cash Flow
NASDAQ:RGNX - Nasdaq - US75901B1070 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -157.69M | -227.10M | -263.49M | -280.30M | 127.80M | |||
| Depreciation Amortization | 15.99M | 16.21M | 17.32M | 12.90M | 9.60M | |||
| Change In Working Capital | 30.10M | 5.53M | -10.89M | 14.00M | 40.20M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | -72.00K | 142.00K | 11.80M | 6.00M | |||
| Other non cash items | 27.56M | 32.23M | 38.65M | 45.90M | 41.30M | |||
| OPERATING CASH FLOW | -84.04M | -173.13M | -218.41M | -207.50M | 218.90M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.90M | -2.44M | -9.96M | -30.70M | -84.20M | |||
| Other Investing Activity | 137.91M | 105.88M | 200.90M | 18.80M | -322.50M | |||
| INVESTING CASH FLOW | 135.01M | 103.45M | 190.94M | -11.90M | -406.60M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 821.00K | 132.86M | 7.80M | 4.30M | 222.50M | |||
| Other Financing Activity | -34.66M | -40.18M | -42.77M | -33.10M | -27.20M | |||
| FINANCING CASH FLOW | -33.84M | 92.68M | -34.97M | -28.80M | 195.30M | |||
| CHANGE IN CASH | 17.13M | 23.00M | -62.43M | -248.20M | 7.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -84.04M | -173.13M | -218.41M | -207.50M | 218.90M | |||
| Capital Expenditure | -2.90M | -2.44M | -9.96M | -30.70M | -84.20M | |||
| FREE CASH FLOW | -86.94M | -175.56M | -228.37M | -238.20M | 134.70M | |||
All data in USD